Dividend Win Wednesday: Semiconductor Capital Equipment at 7× Earnings and 88% Off Peak
Top 5 Pixie Picks
Only Pro and Free Trial readers get meta-analysis of the top 5 ranked Dividend stocks.
Sign in →6. Biogen Inc. (BIIB
Dividend yield: n/a | Payout ratio: 0.0% | 52w drawdown: -3.4%
Biogen shows a 6.7% FCF yield with 76% gross margin, 2.2% revenue growth, and 7% ROIC. The stock is only 3.4% off its 52-week high, trading near $199 against a $219 analyst target for 10% implied upside.
Insiders added 84,208 net shares over six months with a 50.4% buy ratio, the highest conviction signal among the eight names this week. Jesus Mantas, Lloyd Minor, and Maria Freire all filed buys in June; insider dollar volume totals $16.8 million.
The company pays no dividend despite the 6.7% FCF yield, which makes this a capital-appreciation trade, not an income position. Interest coverage at 6.8× is the lowest among the biotech and pharma names on the screen, and net debt/EBITDA at 0.64 means the balance sheet carries leverage.
7. Gilead Sciences, Inc. (GILD)
Dividend yield: 2.6% | Payout ratio: 47.9% | 52w drawdown: -19.4%
Gilead trades at a 6.0% FCF yield with 24.4% ROIC, 79% gross margin, and 2.4% revenue growth. The payout ratio is 47.9%, leaving half the free cash for buybacks or pipeline investment; shareholder yield including repurchases is 1.2%.
Insiders added 283,785 net shares over six months, with Andrew Dickinson and Johanna Mercier filing buys in mid-June. The insider buy ratio is 53% against 30% sells, a net positive signal. News this week showed insider sales totaling $376,200, but the six-month net remains positive.
The stock is down 19.4% from its 52-week high, trading at $126.77 against a $157.83 analyst target for 24.5% implied upside. Next earnings on August 6 show consensus at negative $7.14 EPS, which reflects a one-time charge or restructuring; revenue estimate is $7.4 billion.
8. Exxon Mobil Corporation (XOM)
Dividend yield: 2.9% | Payout ratio: 59.2% | 52w drawdown: -19.9%
Exxon shows a 4.0% FCF yield with 69× interest coverage, the highest debt-service cushion on the screen. ROIC is 11.1%, gross margin is 22%, and the payout ratio is 59%, which funds a 2.9% yield with room for modest growth.
Revenue declined 4.5% year-over-year and the five-year dividend CAGR is negative 10%, which means this is a stability play on energy sector exposure, not a growth dividend. The stock is down 20% from peak and trades at $141 against a $169.91 analyst target for 20% implied upside.
Jeffrey Ubben added 32,250 net shares in late May, the only insider activity in the last 30 days. Western Midstream brought a second produced-water facility online in the Permian this week, expanding the infrastructure footprint for Exxon's basin partners.
What to Watch
- July 21: Novartis earnings (est. $2.11 EPS, $14.1B revenue). Revenue growth at 9.6% year-over-year means consensus is pricing modest expansion; any upside surprise moves the dividend growth narrative.
- July 23: Newmont earnings (est. $2.26 EPS, $6.5B revenue). The new CEO and CFO report their first quarter after the leadership reshuffle; gross margin at 53% sets the bar for operational improvement.
- July 29: Biogen earnings (est. $2.03 EPS, $2.4B revenue). Insiders added $16.8 million in the last six months; the neurology franchise and Alzheimer's pipeline will determine whether the FCF yield holds.
- July 30: KLA earnings (est. $1.00 EPS, $3.6B revenue). The semiconductor capital equipment sector trades at 7× to 10× forward earnings after the 88% drawdown; any upside on WFE demand sends the stock toward analyst targets above $1,800.
Go Deeper
The dividend screener looks for companies with high free cash flow yields, sustainable payout ratios, and drawdowns that create entry points below fair value.
Pro-only analytics
Named tickers from this article open in the app with Pro or an active trial.
Sign in →Stock Pixie Pro
See the full dividend screen — every pick, every metric, every day.
The app shows up to 10 rows on Free; the top 5 by Pixie rank keep ticker, name, and recent close private. Posts may name the top 5 for context. Pro and trial show every row on the screener, full identifiers, and the rest of Pro.
Start your free trial →